Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care.

Authors

Adam F Binder, Thomas Jefferson UniversityFollow
Nathan R Handley, Thomas Jefferson UniversityFollow
Lindsay Wilde, Thomas Jefferson UniversityFollow
Neil Palmisiano, Thomas Jefferson UniversityFollow
Ana Maria Lopez, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-1-2020

Comments

This is the final version of the article from Frontiers in Oncology, 2020, Volume 10: 1183

The published version can be found at: https://doi.org/10.3389/fonc.2020.01183

Copyright Binder et.al

Abstract

In late January 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) was reported as an outbreak in Wuhan, China. Within 2 months it became a global pandemic. Patients with cancer are at highest risk for both contracting and suffering complications of its resultant disease, Coronavirus 19 (COVID-19). Healthcare systems across the world had to adapt quickly to mitigate this risk, while continuing to provide potentially lifesaving treatment to patients. Bringing care to the home through the use of telehealth, home based chemotherapy, and remote patient monitoring technologies can help minimize risk to the patient and healthcare workers without sacrificing quality of care delivered. These care models provide the right treatment, to the right patient, at the right time,

Recommended Citation

Binder, Adam F; Handley, Nathan R; Wilde, Lindsay; Palmisiano, Neil; and Lopez, Ana Maria, "Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care." (2020). Department of Medical Oncology Faculty Papers. Paper 118.
https://jdc.jefferson.edu/medoncfp/118

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

32676459

Language

English